BofA raised the firm’s price target on Intuitive Surgical (ISRG) to $700 from $600 and keeps a Buy rating on the shares. Intuitive’s Q4 operating margin of 38.4% was its highest in 13 quarters and the company posted year-over-year EPS growth of 38%, notes the analyst, who expects continued “outsized” EPS growth.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $688 from $560 at Raymond James
- Intuitive Surgical price target raised to $622 from $561 at BTIG
- Intuitive Surgical price target raised to $707 from $690 at Baird
- Intuitive Surgical price target raised to $670 from $538 at Piper Sandler
- Intuitive Surgical price target raised to $675 from $575 at JPMorgan